SillaJen

Biotechnology ResearchCalifornia, United States11-50 Employees

SillaJen Biotherapeutics operates within the biotechnology research sector, focusing on the research, development, and manufacturing of oncolytic viruses aimed at cancer treatment. Its work encompasses Clinical Operations, Regulatory Affairs, Research and Development, Manufacturing, Alliance Management, and trial accounting, supporting the progression of its therapies through clinical evaluation. The company’s lead program, built on its SOLVETM platform, seeks to advance cancer immunotherapy with an emphasis on solid tumor indications, including advanced primary liver cancer in its latest trial phase. Based in San Francisco, California, the organization sits within a global biotech cluster and maintains a cross-border presence with its roots in South Korea, reflecting a multinational approach to development and collaboration. The firm’s primary customers are researchers and healthcare partners seeking novel cancer treatments, and it aims to address unmet needs by advancing oncolytic immunotherapies through rigorous development and regulatory pathways.

Sign up for free to view info

Email Format Employee directory